Decision making nelle anemie

Translated title of the contribution: Decision making in anemia

G. Barosi

Research output: Contribution to journalArticle

Abstract

Decision making is the most frequently performed cognitive activity in medicine. An epistemological and an operational model of the decision allow to classify the different types of complexity in medical decision making. Decision analysis is a technique that allows to help physician in decision making. It quantifies outcomes valuable for deriving answer to medical decisions since it gives structure to the problem, allows open consideration of all relevant effects of the decision and forces the explicit treatment of key assumptions. Decision analysis has been used to decide whether splenectomy provides utility to patients with mild hereditary spherocytosis. The model suggested that combined prophylactic splenectomy and cholecystectomy provide a substantial gain in quality-adjusted life expectancy for young patients and adults with mild HS and gallstones. A study attempted to determine the cost-effectiveness of performing screening for anemia before starting rHuEPO in new onset end stage renal disease patients. Anemia screening before initiating rHuEPO therapy should be limited to tests to identify iron deficiency. Decision analysis was used to compare the cost- effectiveness of rHuEPO supplemented with red blood cell (RBC) transfusions with conventional treatment with RBC transfusions alone in patients with chemotherapy induced anemia. The incremental cost was greater than $100,000 per quality-adjusted life-year (QALY).

Original languageItalian
Pages (from-to)221-226
Number of pages6
JournalOspedale Maggiore
Volume93
Issue number3
Publication statusPublished - 1999

Fingerprint

Decision Support Techniques
Anemia
Decision Making
Erythrocyte Transfusion
Splenectomy
Cost-Benefit Analysis
Hereditary Spherocytosis
Quality-Adjusted Life Years
Cholecystectomy
Gallstones
Life Expectancy
Chronic Kidney Failure
Young Adult
Therapeutics
Iron
Quality of Life
Medicine
Physicians
Costs and Cost Analysis
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Barosi, G. (1999). Decision making nelle anemie. Ospedale Maggiore, 93(3), 221-226.

Decision making nelle anemie. / Barosi, G.

In: Ospedale Maggiore, Vol. 93, No. 3, 1999, p. 221-226.

Research output: Contribution to journalArticle

Barosi, G 1999, 'Decision making nelle anemie', Ospedale Maggiore, vol. 93, no. 3, pp. 221-226.
Barosi G. Decision making nelle anemie. Ospedale Maggiore. 1999;93(3):221-226.
Barosi, G. / Decision making nelle anemie. In: Ospedale Maggiore. 1999 ; Vol. 93, No. 3. pp. 221-226.
@article{d139ee0208ac4448aa94785fabbc4d97,
title = "Decision making nelle anemie",
abstract = "Decision making is the most frequently performed cognitive activity in medicine. An epistemological and an operational model of the decision allow to classify the different types of complexity in medical decision making. Decision analysis is a technique that allows to help physician in decision making. It quantifies outcomes valuable for deriving answer to medical decisions since it gives structure to the problem, allows open consideration of all relevant effects of the decision and forces the explicit treatment of key assumptions. Decision analysis has been used to decide whether splenectomy provides utility to patients with mild hereditary spherocytosis. The model suggested that combined prophylactic splenectomy and cholecystectomy provide a substantial gain in quality-adjusted life expectancy for young patients and adults with mild HS and gallstones. A study attempted to determine the cost-effectiveness of performing screening for anemia before starting rHuEPO in new onset end stage renal disease patients. Anemia screening before initiating rHuEPO therapy should be limited to tests to identify iron deficiency. Decision analysis was used to compare the cost- effectiveness of rHuEPO supplemented with red blood cell (RBC) transfusions with conventional treatment with RBC transfusions alone in patients with chemotherapy induced anemia. The incremental cost was greater than $100,000 per quality-adjusted life-year (QALY).",
keywords = "Anemia, Chemotherapy-induced anemia, Cost-effectiveness analysis, Decision analysis, Erythropoietin, Recombinant erythropoietin, Splenectomy",
author = "G. Barosi",
year = "1999",
language = "Italian",
volume = "93",
pages = "221--226",
journal = "Ospedale Maggiore",
issn = "0369-7843",
publisher = "Masson Italia Periodici",
number = "3",

}

TY - JOUR

T1 - Decision making nelle anemie

AU - Barosi, G.

PY - 1999

Y1 - 1999

N2 - Decision making is the most frequently performed cognitive activity in medicine. An epistemological and an operational model of the decision allow to classify the different types of complexity in medical decision making. Decision analysis is a technique that allows to help physician in decision making. It quantifies outcomes valuable for deriving answer to medical decisions since it gives structure to the problem, allows open consideration of all relevant effects of the decision and forces the explicit treatment of key assumptions. Decision analysis has been used to decide whether splenectomy provides utility to patients with mild hereditary spherocytosis. The model suggested that combined prophylactic splenectomy and cholecystectomy provide a substantial gain in quality-adjusted life expectancy for young patients and adults with mild HS and gallstones. A study attempted to determine the cost-effectiveness of performing screening for anemia before starting rHuEPO in new onset end stage renal disease patients. Anemia screening before initiating rHuEPO therapy should be limited to tests to identify iron deficiency. Decision analysis was used to compare the cost- effectiveness of rHuEPO supplemented with red blood cell (RBC) transfusions with conventional treatment with RBC transfusions alone in patients with chemotherapy induced anemia. The incremental cost was greater than $100,000 per quality-adjusted life-year (QALY).

AB - Decision making is the most frequently performed cognitive activity in medicine. An epistemological and an operational model of the decision allow to classify the different types of complexity in medical decision making. Decision analysis is a technique that allows to help physician in decision making. It quantifies outcomes valuable for deriving answer to medical decisions since it gives structure to the problem, allows open consideration of all relevant effects of the decision and forces the explicit treatment of key assumptions. Decision analysis has been used to decide whether splenectomy provides utility to patients with mild hereditary spherocytosis. The model suggested that combined prophylactic splenectomy and cholecystectomy provide a substantial gain in quality-adjusted life expectancy for young patients and adults with mild HS and gallstones. A study attempted to determine the cost-effectiveness of performing screening for anemia before starting rHuEPO in new onset end stage renal disease patients. Anemia screening before initiating rHuEPO therapy should be limited to tests to identify iron deficiency. Decision analysis was used to compare the cost- effectiveness of rHuEPO supplemented with red blood cell (RBC) transfusions with conventional treatment with RBC transfusions alone in patients with chemotherapy induced anemia. The incremental cost was greater than $100,000 per quality-adjusted life-year (QALY).

KW - Anemia

KW - Chemotherapy-induced anemia

KW - Cost-effectiveness analysis

KW - Decision analysis

KW - Erythropoietin

KW - Recombinant erythropoietin

KW - Splenectomy

UR - http://www.scopus.com/inward/record.url?scp=0032721495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032721495&partnerID=8YFLogxK

M3 - Articolo

VL - 93

SP - 221

EP - 226

JO - Ospedale Maggiore

JF - Ospedale Maggiore

SN - 0369-7843

IS - 3

ER -